CERA

Close Menu

Donate

Donate to CERA

Subscribe

Get monthly updates

Clinical trials

Take part in research
Close Close

New avenues for AMD: Annual Review 2024

Our macular researchers are on the forefront of new discoveries in AMD, from improving how we understand the risk factors for vision loss to developing a gene therapy technique that could replace regular eye injections.

Stories

Research journey

Olga Maxwell, who has age-related macular degeneration, has been participating in eye research for over a decade.

Read More

Editing genes to end regular eye injections

New research targeting the body’s genetic messengers could be the key to ending regular eye injections for AMD.

Read More

Global study uncovers AMD mysteries

An international study led by CERA, WEHI and the University of Melbourne has found a genetic clue about the people at high risk of losing their vision from macular degeneration. 

Read More

Growing CERA’s supporter community

Chair of CERA’s Philanthropy and Engagement Committee Alexandra Grimwade is inspiring others to support research that protects vision.

Read More

Sleep apnoea linked to macular degeneration

New findings from CERA research suggests sleep apnoea could be a modifiable risk factor for AMD.

Read More
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.